Issued Patents All Time
Showing 1–17 of 17 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11027010 | Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids | Thierry Batard, Bertrand Villet | 2021-06-08 |
| 11028441 | IL-10 as a predictive biomarker of responsiveness to house dust mite allergen immunotherapy | Laurent Mascarell, Véronique Bodo, Vincent C. Lombardi, Claire Gueguen | 2021-06-08 |
| 11015221 | Markers of immune response | Laurent Mascarell, Claire Gueguen, Emmanuel Nony, Véronique Bodo | 2021-05-25 |
| 10884002 | Sialylated fetuin-A as a marker of immunotherapy efficacy | Vincent C. Lombardi, Noémie CAILLOT, Emmanuel Nony, Véronique Bodo, Julien Bouley | 2021-01-05 |
| 10610586 | Compositions for antigen-specific induction of tolerance | Laurence Van Overtvelt, Alain Razafindratsita | 2020-04-07 |
| 10190166 | Methods for identifying dendritic cell subsets, for determining if a patient is developing a regulatory or an effector immune response, and for determining response to immunotherapy | Aline Zimmer, Julien Bouley, Laurent Mascarell, Emmanuel Nony | 2019-01-29 |
| 10101341 | Biomarkers of immunotherapy efficacy | Véronique Bodo, Julien Bouley, Emmanuel Nony, Hélène Moussu, Karine Jain | 2018-10-16 |
| 9868770 | Recombinant Der P 2 expressed in Pichia Pastoris as a “natural-like” allergen for immunotherapy and diagnostic purposes | Véronique Bordas, Laetitia Bussieres, Sabi Airouche, Sophie Tourdot, Emmanuel Nony +1 more | 2018-01-16 |
| 9822185 | Use of IGG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and incidents via the mucosa | Thierry Batard, Laurent Mascarell, Aline Zimmer, Emmanuel Nony | 2017-11-21 |
| 9795644 | Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids | Thierry Batard, Bertrand Villet | 2017-10-24 |
| 9555102 | Compositions for antigen-specific induction of tolerance | Laurence Van Overtvelt, Alain Razafindratsita | 2017-01-31 |
| 9480748 | Mucoadhesive particulate formulation for inducing antigen-specific immune tolerance | Nathalie Saint-Lu, Alain Razafindratsita, Sophie Tourdot, Laurence Van Overtvelt | 2016-11-01 |
| 9187568 | Use of IgG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and manifestations via the mucosal route | Thierry Batard, Laurent Mascarell, Aline Zimmer, Emmanuel Nony | 2015-11-17 |
| 8632993 | Method for grass species identification | Thierry Batard, Emmanuel Nony | 2014-01-21 |
| 8257717 | Immunogenic polypeptides encoded by MAGE minigenes and uses thereof | Neil Berinstein, James Tartaglia, John A. Tine, Thierry Boon-Falleur, Pierre Vander Bruggen | 2012-09-04 |
| 8017590 | Method of inducing and/or enhancing an immune response to tumor antigens | Neil Berinstein, James Tartaglia, Brian Barber | 2011-09-13 |
| 7851212 | Immunogenic polypeptides encoded by MAGE minigenes and uses thereof | Neil Berinstein, James Tartaglia, John A. Tine, Thierry Boon-Falleur, Pierre Vander Bruggen | 2010-12-14 |